Published journal articles

Currently Being Edited

2016   2015   2014   2013   2012   2011   2010 and previous






Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening. Scanlon PH, Aldington SJ, Leal J, Luengo-Fernandez R, Oke J, Sivaprasad S, Gazis A, Stratton IM. NIHR Journals Library; 2015 Sep. (Health Technology Assessment, No. 19.74.)

Available from:

Prevalence and incidence of blindness and other degrees of sight impairment in patients treated for neovascular age related macular degeneration in a well-defined region of the United Kingdom. Buckle M, Lee A, Mohamed Q, Fletcher E, Sallam A, Healy R, Stratton IM, Tufail A, Johnston RL. Eye advance online publication, 16 January 2015;doi:10.1038/eye.2014.296

Menopausal Status and Abdominal Obesity Are Significant Determinants of Hepatic Lipid Metabolism in Women. Hodson L, Banerjee R, Rial B, Arlt W, Adiels M, Boren J, Marinou K, Fisher C, Mostad IL, Stratton IM, Barrett PHR, Chan DC, Watts GF, Harnden K, Karpe F, Fielding BA. J Am Heart Assoc. 2015;4:e002258 doi: 10.1161/JAHA.115.002258




Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives. Simó R, Hernández C; on behalf of the European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR). Trends Endocrinol Metab 2014;25:23-33

Risk stratification for diabetic eye screening [letter]. Stratton IM, Aldington SJ.  Diabetologia 2014; 57(1): 259 doi: 10.1007/s00125-013-3060-4. Epub 2013 Sep 22

Influence of primary care practices on patients' uptake of diabetic retinopathy screening: a qualitative case study. Lindenmeyer A, Sturt JA, Hipwell A, Stratton IM, Al-Athamneh N, Gadsby R, O'Hare JP, Scanlon PH. Br J Gen Pract 2014;64(625): e484-492.

Delay in Diabetic Retinopathy Screening Increases the Rate of Detection of Referable Diabetic Retinopathy. Scanlon PH, Aldington SJ, Stratton IM. Diabetic Med 2014;31(4): 439-442.

The use of weighted health-related Quality of Life scores in people with diabetic macular oedema at baseline in a randomized clinical trial. Scanlon PH, Loftus J, Starita C, Stratton IM. Diabetic Med 2014 Sep 23; doi: 10.1111/dme.12593. [Epub ahead of print]



A simple algorithm to estimate the time to development of sight-threatening diabetic retinopathy. Stratton IM, Adler AI, Aldington SJ, Histed MJ, Taylor DJ, Scanlon PH. Published Online November 23, 2012. For all Public Health Abstracts see

Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?Ross AH, Donachie PH, Sallam A, Stratton IM, Mohamed Q, Scanlon PH, Kirkpatrick JN, Johnston RL.  Eye (Lond). 2013 Jan;27(1):56-64.

A simple risk stratification for time to development of sight threatening diabetic retinopathy. Stratton IM, Aldington SJ, Taylor DJ, Adler AI, Scanlon PH. Diabetes Care 2013 Mar;36(3):580-5.

The influence of background diabetic retinopathy in the second eye on rates of progression of diabetic retinopathy between 2005 and 2010. Scanlon PH, Stratton IM, Histed M, Chave SJ, Aldington SJ.  Acta Ophthalmol 2013;91(5): 335-339. doi: 10.1111/aos.12074.

A Simple Risk Stratification for Time to Development of Sight-Threatening Diabetic Retinopathy. Stratton IM,  Aldington SJ, Taylor DJ, Adler AI, Scanlon PH. Diabetes Care 2013;36(3): 580-585. doi: 10.2337/ dc12-0625.  PubMed PMID: 23150285.

"United Kingdom National Ophthalmology Database Study: Diabetic Retinopathy; Report 1: prevalence of centre-involving diabetic macular oedema and other grades of maculopathy and retinopathy in hospital eye services." Keenan, T. D., et al.  Eye (Lond). 2013; 27(12): 1397-1404.

Updating Diabetic Retinopathy screening lists using automatic extraction from GP patient records. Scanlon PH, Provins EK, Craske S, Chave SJ, Aldington SJ, Martin CN, Stratton IM.  J Med Screen 2013;20(3): 111-117.

Epidemiological issues in diabetic retinopathy. Scanlon PH, Aldington SJ, Stratton IM. Middle East Afr J Ophthalmol 2013 Oct-Dec;20(4): 293-300.

Agreement between photographic screening and hospital biomicroscopy grading of diabetic retinopathy and maculopathy. Healy R, Sallam A, Jones V, Donachie PH, Scanlon PH, Stratton IM, Johnston RL. Eur J Ophthalmol 2013; epub







Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT Programme. Sjølie AK, Klein R, Porta M, Orchard T, Fuller J, Parving HH, Bilous R, Aldington S, Chaturvedi N.  Diabetic Med 2011;28(3): 345-351. doi: 10.1111/j.1464-5491.2010.03210.x. PubMed PMID: 21309844.


2010 and previous

The influence of age and duration of diabetes on image quality in non-mydriatic & mydriatic digital photographic screening. Scanlon PH, Foy C, Malhotra R, Aldington SJ.  Diabetes Care 2005;(28)10: 2448-2453

Grading and disease management in national screening for diabetic retinopathy in England and Wales. Harding S, Greenwood R, Aldington S, Gibson J, Owens D, Taylor R, Kohner E, Scanlon P & Leese G.  Diabetic Med 2003;20(12): 965-971

The effectiveness of screening for diabetic retinopathy by digital imaging photography and technician ophthalmoscopy. Scanlon PH, Malhotra R, Thomas G, Foy C, Kirkpatrick JN, Lewis-Barned N, Harney B, Aldington SJ.  Diabetic Med 2003;20(6): 467-474

Comparison of two reference standards in validating two-field mydriatic digital photography as a method of screening for diabetic retinopathy. Scanlon PH, Malhotra R, Greenwood RH, Aldington SJ, Foy C, Flatman M, Downes S.  Br J Ophthalmol 2003;87(10):1258-1263

Screening for diabetic retinopathy: developing a standardized photographic protocol for St. John's Hospital. Herd H, Aldington SJ. J Audiov Media Med. 2002;25(1): 28-33


Top of page ▲

Site last updated 12/09/2018